Main variables;Main activity, secondary one or a tool necessary for production;Total
Companies that carry out R&D in Biotechnology;Total;1.056
Companies that carry out R&D in Biotechnology;Main;551
Companies that carry out R&D in Biotechnology;Secondary dwellings;183
Companies that carry out R&D in Biotechnology;Tool;323
%Companies according to biotechnology used: Genetic code;Total;36
%Companies according to biotechnology used: Genetic code;Main;46
%Companies according to biotechnology used: Genetic code;Secondary dwellings;22
%Companies according to biotechnology used: Genetic code;Tool;26
%Companies according to biotechnology used: Functional units;Total;45
%Companies according to biotechnology used: Functional units;Main;51
%Companies according to biotechnology used: Functional units;Secondary dwellings;38
%Companies according to biotechnology used: Functional units;Tool;38
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total;27
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Main;33
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Secondary dwellings;21
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Tool;21
%Companies according to biotechnology used: Bioprocesses;Total;47
%Companies according to biotechnology used: Bioprocesses;Main;41
%Companies according to biotechnology used: Bioprocesses;Secondary dwellings;48
%Companies according to biotechnology used: Bioprocesses;Tool;55
%Companies according to biotechnology used: Sub-cellular organisms;Total;8
%Companies according to biotechnology used: Sub-cellular organisms;Main;12
%Companies according to biotechnology used: Sub-cellular organisms;Secondary dwellings;8
%Companies according to biotechnology used: Sub-cellular organisms;Tool;4
%Companies according to biotechnology used: Bio-computing;Total;25
%Companies according to biotechnology used: Bio-computing;Main;33
%Companies according to biotechnology used: Bio-computing;Secondary dwellings;13
%Companies according to biotechnology used: Bio-computing;Tool;17
%Companies according to biotechnology used: Nanobiotechnology;Total;13
%Companies according to biotechnology used: Nanobiotechnology;Main;18
%Companies according to biotechnology used: Nanobiotechnology;Secondary dwellings;12
%Companies according to biotechnology used: Nanobiotechnology;Tool;5
%Companies according to biotechnology used: Other;Total;15
%Companies according to biotechnology used: Other;Main;16
%Companies according to biotechnology used: Other;Secondary dwellings;16
%Companies according to biotechnology used: Other;Tool;13
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total;49
%Company by field(s) of ultimate application of biotechnology use: Human Health;Main;65
%Company by field(s) of ultimate application of biotechnology use: Human Health;Secondary dwellings;38
%Company by field(s) of ultimate application of biotechnology use: Human Health;Tool;27
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;20
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Main;25
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Secondary dwellings;19
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Tool;13
%Company by field(s) of ultimate application of biotechnology use: Food products;Total;30
%Company by field(s) of ultimate application of biotechnology use: Food products;Main;23
%Company by field(s) of ultimate application of biotechnology use: Food products;Secondary dwellings;31
%Company by field(s) of ultimate application of biotechnology use: Food products;Tool;42
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total;23
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Main;20
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Secondary dwellings;24
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Tool;26
%Company by field(s) of ultimate application of biotechnology use: Environment;Total;13
%Company by field(s) of ultimate application of biotechnology use: Environment;Main;11
%Company by field(s) of ultimate application of biotechnology use: Environment;Secondary dwellings;25
%Company by field(s) of ultimate application of biotechnology use: Environment;Tool;11
%Company by field(s) of ultimate application of biotechnology use: Industry;Total;12
%Company by field(s) of ultimate application of biotechnology use: Industry;Main;13
%Company by field(s) of ultimate application of biotechnology use: Industry;Secondary dwellings;19
%Company by field(s) of ultimate application of biotechnology use: Industry;Tool;7
Personnel in R&D in biotechnology (no. of persons);Total;10.719
Personnel in R&D in biotechnology (no. of persons);Main;5.901
Personnel in R&D in biotechnology (no. of persons);Secondary dwellings;1.572
Personnel in R&D in biotechnology (no. of persons);Tool;3.245
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;6.131
Personnel in R&D in biotechnology (no. of persons): Researchers;Main;3.640
Personnel in R&D in biotechnology (no. of persons): Researchers;Secondary dwellings;912
Personnel in R&D in biotechnology (no. of persons): Researchers;Tool;1.579
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;4.588
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Main;2.261
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Secondary dwellings;661
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Tool;1.667
Personnel in R&D in biotechnology (no. of persons): women;Total;6.040
Personnel in R&D in biotechnology (no. of persons): women;Main;3.443
Personnel in R&D in biotechnology (no. of persons): women;Secondary dwellings;844
Personnel in R&D in biotechnology (no. of persons): women;Tool;1.753
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;3.411
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Main;2.087
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Secondary dwellings;511
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Tool;812
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;2.629
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Main;1.356
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Secondary dwellings;333
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Tool;941
Personnel in R&D in biotechnology (FTE);Total;7.751
Personnel in R&D in biotechnology (FTE);Main;4.659,2
Personnel in R&D in biotechnology (FTE);Secondary dwellings;980,5
Personnel in R&D in biotechnology (FTE);Tool;2.111,1
Personnel in R&D in biotechnology (FTE): Researchers;Total;4.518,1
Personnel in R&D in biotechnology (FTE): Researchers;Main;2.855,6
Personnel in R&D in biotechnology (FTE): Researchers;Secondary dwellings;621
Personnel in R&D in biotechnology (FTE): Researchers;Tool;1.041,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;3.232,7
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Main;1.803,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Secondary dwellings;359,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Tool;1.069,6
Personnel in R&D in biotechnology (FTE): women;Total;4.471,4
Personnel in R&D in biotechnology (FTE): women;Main;2.697,8
Personnel in R&D in biotechnology (FTE): women;Secondary dwellings;549,7
Personnel in R&D in biotechnology (FTE): women;Tool;1.223,9
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;2.562,7
Personnel in R&D in biotechnology (FTE): (women) Researchers;Main;1.637,8
Personnel in R&D in biotechnology (FTE): (women) Researchers;Secondary dwellings;360,6
Personnel in R&D in biotechnology (FTE): (women) Researchers;Tool;564,3
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;1.908,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Main;1.060
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Secondary dwellings;189,1
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Tool;659,6
Internal expenditure on R&D (thousands of euros);Total;679.558
Internal expenditure on R&D (thousands of euros);Main;446.123
Internal expenditure on R&D (thousands of euros);Secondary dwellings;82.011
Internal expenditure on R&D (thousands of euros);Tool;151.424
1) By nature of the expense: Current expenses;Total;634.631
1) By nature of the expense: Current expenses;Main;412.211
1) By nature of the expense: Current expenses;Secondary dwellings;78.386
1) By nature of the expense: Current expenses;Tool;144.035
1.1) Remuneration to researchers;Total;228.857
1.1) Remuneration to researchers;Main;153.206
1.1) Remuneration to researchers;Secondary dwellings;31.881
1.1) Remuneration to researchers;Tool;43.769
1.2) Remuneration to technicians and assistants;Total;104.498
1.2) Remuneration to technicians and assistants;Main;61.567
1.2) Remuneration to technicians and assistants;Secondary dwellings;12.726
1.2) Remuneration to technicians and assistants;Tool;30.205
1.3) Other current expenses;Total;301.276
1.3) Other current expenses;Main;197.437
1.3) Other current expenses;Secondary dwellings;33.779
1.3) Other current expenses;Tool;70.060
2) By nature of the expense: Capital expenses;Total;44.927
2) By nature of the expense: Capital expenses;Main;33.912
2) By nature of the expense: Capital expenses;Secondary dwellings;3.625
2) By nature of the expense: Capital expenses;Tool;7.389
2.1) Land and buildings;Total;2.585
2.1) Land and buildings;Main;2.159
2.1) Land and buildings;Secondary dwellings;90
2.1) Land and buildings;Tool;337
2.2) Equipment and instruments;Total;23.569
2.2) Equipment and instruments;Main;14.228
2.2) Equipment and instruments;Secondary dwellings;3.239
2.2) Equipment and instruments;Tool;6.101
2.3) Acquisition of specific R+D software;Total;1.392
2.3) Acquisition of specific R+D software;Main;709
2.3) Acquisition of specific R+D software;Secondary dwellings;128
2.3) Acquisition of specific R+D software;Tool;555
2.4) Otros productos de propiedad intelectual específicos para I+D;Total;17.381
2.4) Otros productos de propiedad intelectual específicos para I+D;Main;16.817
2.4) Otros productos de propiedad intelectual específicos para I+D;Secondary dwellings;168
2.4) Otros productos de propiedad intelectual específicos para I+D;Tool;396
1) By origin of the funds: National funds;Total;556.297
1) By origin of the funds: National funds;Main;336.896
1) By origin of the funds: National funds;Secondary dwellings;71.496
1) By origin of the funds: National funds;Tool;147.904
1.1) Own funds;Total;387.010
1.1) Own funds;Main;240.941
1.1) Own funds;Secondary dwellings;42.317
1.1) Own funds;Tool;103.752
1.2) From companies;Total;86.025
1.2) From companies;Main;41.093
1.2) From companies;Secondary dwellings;17.175
1.2) From companies;Tool;27.757
1.3) Public Administration funds;Total;74.764
1.3) Public Administration funds;Main;49.704
1.3) Public Administration funds;Secondary dwellings;11.115
1.3) Public Administration funds;Tool;13.944
1.4) From Universities;Total;408
1.4) From Universities;Main;340
1.4) From Universities;Secondary dwellings;2
1.4) From Universities;Tool;66
1.5) From non profit private institutions;Total;8.090
1.5) From non profit private institutions;Main;4.818
1.5) From non profit private institutions;Secondary dwellings;887
1.5) From non profit private institutions;Tool;2.385
1) By origin of the funds: Foreign funds;Total;123.262
1) By origin of the funds: Foreign funds;Main;109.227
1) By origin of the funds: Foreign funds;Secondary dwellings;10.514
1) By origin of the funds: Foreign funds;Tool;3.520
2.1) From EU programmes;Total;25.125
2.1) From EU programmes;Main;14.287
2.1) From EU programmes;Secondary dwellings;7.967
2.1) From EU programmes;Tool;2.871
2.2) Other foreign funds;Total;98.137
2.2) Other foreign funds;Main;94.940
2.2) Other foreign funds;Secondary dwellings;2.547
2.2) Other foreign funds;Tool;649
Purchase of R&D services in biotechnology (thousands of euros);Total;147.558
Purchase of R&D services in biotechnology (thousands of euros);Main;104.940
Purchase of R&D services in biotechnology (thousands of euros);Secondary dwellings;19.473
Purchase of R&D services in biotechnology (thousands of euros);Tool;23.146
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total;76.875
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Main;54.648
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Secondary dwellings;12.216
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Tool;10.011
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total;70.683
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Main;50.292
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Secondary dwellings;7.256
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Tool;13.135
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;49
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Main;59
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Secondary dwellings;45
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Tool;32
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Main;11
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Secondary dwellings;20
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Tool;15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;16
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Main;13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Secondary dwellings;25
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Tool;17
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;13
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Main;12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Secondary dwellings;21
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Tool;10
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Total;18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Main;20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Secondary dwellings;24
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Tool;12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Total;18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Main;21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Secondary dwellings;19
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Tool;11
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Total;17
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Main;16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Secondary dwellings;21
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Tool;16
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Main;40
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Secondary dwellings;39
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Tool;33
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Total;51
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Main;56
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Secondary dwellings;52
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Tool;44
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;18
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Main;17
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Secondary dwellings;22
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Tool;18
% Companies that have requested biotechnology patents;Total;16
% Companies that have requested biotechnology patents;Main;23
% Companies that have requested biotechnology patents;Secondary dwellings;9
% Companies that have requested biotechnology patents;Tool;6
Number of patents requested;Total;746
Number of patents requested;Main;539
Number of patents requested;Secondary dwellings;142
Number of patents requested;Tool;65
% Companies with income of an international origin related to biotechnological activities;Total;23,3
% Companies with income of an international origin related to biotechnological activities;Main;33,8
% Companies with income of an international origin related to biotechnological activities;Secondary dwellings;11,6
% Companies with income of an international origin related to biotechnological activities;Tool;12
% Turnover representing income of an international origin related to biotechnological activities;Total;1,2
% Turnover representing income of an international origin related to biotechnological activities;Main;14,5
% Turnover representing income of an international origin related to biotechnological activities;Secondary dwellings;0
% Turnover representing income of an international origin related to biotechnological activities;Tool;0,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Total;60,4
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Main;66,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Secondary dwellings;74,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Tool;24,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Total;39,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Main;33,4
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Secondary dwellings;25,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Tool;75,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total;80,9
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Main;78
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Secondary dwellings;70,6
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Tool;98,2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total;17,8
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Main;21,3
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Secondary dwellings;0,3
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Tool;1,3
% Income of an international origin related with activities according to the classification: Operating source abroad;Total;1,3
% Income of an international origin related with activities according to the classification: Operating source abroad;Main;0,6
% Income of an international origin related with activities according to the classification: Operating source abroad;Secondary dwellings;29
% Income of an international origin related with activities according to the classification: Operating source abroad;Tool;0,6
% Income of an international origin related with activities according to the classification: Other;Total;0,1
% Income of an international origin related with activities according to the classification: Other;Main;0,1
% Income of an international origin related with activities according to the classification: Other;Secondary dwellings;0
% Income of an international origin related with activities according to the classification: Other;Tool;0